Promoting Medication Adherence Program in Persons with Schizophrenia in Psychiatric wardkalasin Hospital.

Abstract

Background: Schizophrenia has a strong need for drug treatment to control symptoms, found that in 2017-2019 psychiatric wards. Kalasin Hospital The factors that led to a second or re-admit were found 60% of the drug was missing and followed by 20% of the lack of caregivers.

Objective: This research aimed to examine the effectiveness of the Promoting Medication Adherence Program among persons with schizophrenia Psychiatric  ward in Kalasin Hospital.

Material and Methods: Is quasi-experimental Research design one group pre-test – post-test design The sample consisted of 60 persons are male 51, female 9, and caregivers with schizophrenia 30.  The study was conducted from June 1st to August 31st, 2020. Research instruments composed of the Promoting Medication Adherence Program All instruments were tested for validity by 3 experts.

Results: The results of the study found that: after adherence  program, were higher than before adherence program. The results of this study indicate that participating in adherence program can improve medication use behaviors and attitudes towards treatment for patients and caregivers with schizophrenia.Want to take care of the patient to continue taking the drug.

Conclusions:Encouraging patients tocontinue in taking medication absolutely necessary that the patient and family or caregivers must have knowledge schizophrenia and drug treatment and individual counseling. As well as providing experience by practicing drug management skillsalong with encouraging family or caregivers to take part in caring  for a better quality of life.